M&T Bank’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,647
| Closed | -$397K | – | 1585 |
|
|
2022
Q1 | $397K | Sell |
5,647
-10
| -0.2% | -$703 | ﹤0.01% | 1085 |
|
|
2021
Q4 | $545K | Buy |
5,657
+925
| +20% | +$89.1K | ﹤0.01% | 981 |
|
|
2021
Q3 | $412K | Buy |
4,732
+324
| +7% | +$28.2K | ﹤0.01% | 1094 |
|
|
2021
Q2 | $361K | Buy |
4,408
+1,587
| +56% | +$130K | ﹤0.01% | 1179 |
|
|
2021
Q1 | $268K | Sell |
2,821
-4,096
| -59% | -$389K | ﹤0.01% | 1284 |
|
|
2020
Q4 | $429K | Hold |
6,917
| – | – | ﹤0.01% | 1138 |
|
|
2020
Q3 | $411K | Buy |
6,917
+725
| +12% | +$43.1K | ﹤0.01% | 1078 |
|
|
2020
Q2 | $433K | Sell |
6,192
-63
| -1% | -$4.41K | ﹤0.01% | 1002 |
|
|
2020
Q1 | $284K | Buy |
+6,255
| New | +$284K | ﹤0.01% | 1154 |
|
|
2018
Q4 | – | Sell |
-1,597
| Closed | -$274K | – | 1454 |
|
|
2018
Q3 | $274K | Sell |
1,597
-420
| -21% | -$72.1K | ﹤0.01% | 1274 |
|
|
2018
Q2 | $261K | Sell |
2,017
-529
| -21% | -$68.5K | ﹤0.01% | 1294 |
|
|
2018
Q1 | $262K | Sell |
2,546
-575
| -18% | -$59.2K | ﹤0.01% | 1295 |
|
|
2017
Q4 | $267K | Buy |
3,121
+582
| +23% | +$49.8K | ﹤0.01% | 1293 |
|
|
2017
Q3 | $216K | Buy |
+2,539
| New | +$216K | ﹤0.01% | 1381 |
|